Navigation Links
Jazz Pharmaceuticals Reports Full Year And Fourth Quarter 2012 Financial Results
Date:2/26/2013

ompany's intellectual property rights; obtaining appropriate pricing and reimbursement for the company's products in an increasingly challenging environment; ongoing regulation and oversight by U.S. and non-U.S. regulatory agencies; dependence on key customers and sole source suppliers; the difficulty and uncertainty of pharmaceutical product development and the uncertainty of clinical success and regulatory approval; the company's ability to identify and acquire, in-license or develop additional products or product candidates to grow its business; and potential restrictions on the company's ability and flexibility to pursue future opportunities as a result of its substantial outstanding debt obligations; as well as risks related to future opportunities and plans, including the uncertainty of expected future financial performance and results; and those risks detailed from time-to-time under the caption "Risk Factors" and elsewhere in Jazz Pharmaceuticals plc's Securities and Exchange Commission filings and reports (Commission File No. 001-33500), including in the Quarterly Report on Form 10-Q for the quarter ended September 30, 2012 and future filings and reports by the company, including the Annual Report on Form 10-K for the year ended December 31, 2012 . Jazz Pharmaceuticals undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations. JAZZ PHARMACEUTICALS PLC  CONDENSED CONSOLIDATED STATEMENTS OF INCOME  (In thousands, except per share amounts)  (Unaudited) Three Months EndedYear EndedDecember 31,December 31,2012201120122011 Revenues:  Product sales, net 

$ 181,942$ 80,935$ 580,527$ 266,518 Royalties and contract revenues 

1,7612,6015,4525,759 Total revenues 

183,70383,536585,979272,277 Operating ex
'/>"/>

SOURCE Jazz Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... YORK , Aug. 27, 2014 ... new market research report is available ... Chinese Guidebook for Application and Approval ... Regulations to Practices (2014 Edition) ... Now, Chinese regulations ...
(Date:8/27/2014)... -- CVS Caremark (NYSE: CVS ) announced today ... MedStar Health, a leading health care system with ten ... Washington, DC , region, which will ... patients. Through this clinical affiliation, MedStar Health patients will ... chronic disease monitoring and wellness programs at CVS/pharmacy stores ...
(Date:8/27/2014)... 27, 2014 Amgen (NASDAQ: AMGN ... (FDA) has granted priority review designation for ivabradine for ... an oral drug that inhibits the I ... the body,s cardiac pacemaker. 1 Ivabradine works to ... contractility or ventricular repolarization. 1 Heart failure is ...
Breaking Medicine Technology:Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 2Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 4Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 5Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 6Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 7Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 8Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 9Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 10CVS Caremark Announces New Clinical Affiliation with MedStar Health 2CVS Caremark Announces New Clinical Affiliation with MedStar Health 3FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 2FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 3FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 4FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 5FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 6FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 7
... 18, 2007 /PRNewswire-FirstCall/ -- Vical,Incorporated today announced that ... following interim analysis of data,from the first 41 ... an,angiogenesis product candidate using Vical's DNA delivery,technology. Based ... the trial had been achieved with statistical,significance and ...
... Primary Endpoint of Improvement in Overall,Survival, WESTMINSTER, ... Inc. today announced top line results from,ENRICH, ... Efaproxyn ,(efaproxiral) plus whole brain radiation therapy ... breast cancer. The study,failed to achieve its ...
Cached Medicine Technology:Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 2Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 3Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 4Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 5Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 2Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 3Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 4Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 5Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 6
(Date:8/27/2014)... Spine Guide has built a reputation for ... spinal health. Now, the e-health site will offer new ... back pain symptoms. Spine Guide specializes in three types ... spine surgery. , Some of the most common back ... pain radiating down the leg, inability to stand up ...
(Date:8/27/2014)... Beach, Florida (PRWEB) August 28, 2014 ... Kevin Harrington, Chairman of As Seen On TV, Inc., ... as “The Millionaire Maker”. as Excelerate attendees will learn ... and will have the ability to pitch to an ... World Renowned Business Experts and Millionaire Mentors directly to ...
(Date:8/27/2014)... When it comes to the bedroom, most homeowners want ... breaking the bank in the process. Regardless of whether individuals ... for the master bedroom or simply looking for something inexpensive ... during their Labor Day mattress promotion. , This Labor ... for the home, while enjoying free delivery. Beyond bringing the ...
(Date:8/27/2014)... San Diego, CA (PRWEB) August 27, 2014 ... homeowner insurance policies will now be easier for the ... home insurance prices that are promoted in all 50 ... http://quotespros.com/homeowners-insurance.html . , The different insurers that are ... have made it possible for adults to use the ...
(Date:8/27/2014)... August 27, 2014 Locating an approximate ... consumer to present personal information before rates would be ... that life insurance quotes are distributed online using its ... term plans that an adult has access to review ... U.S. companies. The system for quotation distribution built in ...
Breaking Medicine News(10 mins):Health News:Spine Guide Offering New Overview of Surgical Options For Back Pain 2Health News:Bedding Mart, Top Mattress Store in Broken Arrow Oklahoma, Announces a Huge Labor Day Sale 2Health News:Home Insurance Prices for All 50 States Now Supplied at Consumer Insurance Portal Online 2Health News:Life Insurance Quotes for Term Policies Now Found at Insurer Website Online 2
... Aug. 8 (HealthDay News) -- The most effective treatment for ... the continuous positive airway pressure (CPAP) machine, according to a ... mask while the patient sleeps. This treatment is highly effective ... according to the review of available evidence. However, side ...
... By Amanda Gardner HealthDay Reporter , MONDAY, Aug. ... who has cardiac catheterization to diagnose heart disease is found ... But in other hospitals, relatively few are found to have ... patients may be getting unnecessary procedures, according to a study ...
... (August 8, 2011) The use of Acute Care Emergency ... significant reductions in key patient measures, such as length of ... ED overcrowding), according to a study published in the August ... Surgeons . Emergency departments are a crucial point of access ...
... Prenatal pet exposure, a mother,s delivery mode and race are ... 2, according to a Henry Ford Hospital study. In a ... researchers found that babies who have indoor prenatal pet exposure have ... IgE, between birth and age 2. IgE is linked to the ...
... -- The discovery of a gene pattern that distinguishes highly ... may help improve treatment of bone cancer in children, according ... species that develops bone cancer spontaneously with any frequency. Dogs ... human and dog forms of bone cancer are very similar, ...
... have radical surgery at university hospitals can benefit from excellent ... death rates, according to research in the August issue of ... 2,287 patients who had radical cystectomy surgery, where the bladder ... The surgery was performed at eight Canadian academic centres between ...
Cached Medicine News:Health News:CPAP Therapy Most Effective for Sleep Apnea, Experts Say 2Health News:CPAP Therapy Most Effective for Sleep Apnea, Experts Say 3Health News:Hospitals Vary Widely in Rate of Heart Procedures: Study 2Health News:Hospitals Vary Widely in Rate of Heart Procedures: Study 3Health News:Urgent assessment in emergency departments can reduce surgical decision time and overcrowding 2Health News:Prenatal pet exposure, delivery mode, race are key factors in early allergy risk 2Health News:Study of Bone Cancer in Dogs May Improve Treatment in Kids 2Health News:Improved radical surgery techniques provide positive outcomes for bladder cancer patients 2
... monoclonal antibody based colorimetric test intended ... gonorrhoeae. The test requires less than ... heating or pretreatment. The test does ... cultures. GonoGen&trade II eliminates agglutination, guesswork, ...
... GonoGen™ is a monoclonal ... for the confirmatory identification of ... not require isolated, viable or ... specimen and two minute rotation, ...
Rapid Test Kit...
... a novel device for the growth ... and Neisseria meningitidis. This product ... is easily transportable as a self-contained ... and examine the growth of organisms ...
Medicine Products: